Applied DNA Sciences, Inc. - Common Stock (BNBX)
3.8900
-0.9100 (-18.96%)
NASDAQ · Last Trade: Oct 23rd, 5:31 PM EDT
Detailed Quote
Previous Close | 4.800 |
---|---|
Open | 4.250 |
Bid | 3.750 |
Ask | 4.000 |
Day's Range | 3.420 - 4.350 |
52 Week Range | 3.360 - 6.170 |
Volume | 1,229,605 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 5,065,324 |
Chart
News & Press Releases
Via Benzinga · October 23, 2025
Via Benzinga · October 23, 2025
Via Benzinga · October 23, 2025
Applied DNA Sciences Becomes a B2i Digital Featured Company to Share Its Strategic Rebrand and BNB-Focused Treasury Shift With Investors
Rebranding Reflects the Company’s Expansion From Nucleic Acid Manufacturing to a Broader Platform Integrating Digital Asset Management
Via TheNewswire.com · October 15, 2025
Shares of Synergy CHC Corp. (NASDAQ: SNYR) climbed 13.86% to $2.88 in early trading on strong volume following news of an expanded retail rollout for its flagship FOCUSfactor® supplements and Focus + Energy functional beverages . The expansion brings new distribution through Kroger Co. (NYSE: KR), Wakefern’s ShopRite Ltd. (OTC: SRHGF) , and PriceSmart Inc. (NASDAQ: PSMT) —broadening the brand’s footprint across the U.S., Canada, and Latin America .
Via AB Newswire · October 22, 2025
Via Benzinga · October 22, 2025
Via Benzinga · October 22, 2025
Applied DNA Sciences, Inc. (NASDAQ: BNBX) (“Applied DNA”, “BNBX” or the “Company”), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity (“PIPE”) financing led by institutional DeFi and TradFi investors.
By Applied DNA Sciences, Inc. · Via Business Wire · October 22, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 15, 2025